Bharat Biotech debunks 'political pressure' claims regarding authorisation of Covaxin. It asserts that 'scientific approach was followed.'
A recent report by STAT has emerged about Covaxin and its maker, Bharat Biotech. The investigation suggests that the Hyderabad-based Covaxin developer, Bharat Biotech, had skipped some steps of the Central Drug Standards Control Organization (CDSCO).
According to the report, the Covaxin was rushed due to 'political pressure,' and as a result, it skipped various safeguards in the process before making it available for people.
THIS IS A BREAKING STORY. UPDATES SOON
WAVES Film Bazaar 2025: A Space To Show Up, Collaborate And Grow Together
Market Outlook: Technical Call Of The Day & Top 5 Stocks In Focus For November 20, 2025
US Approves $93 Million Arms Deal With India — What Does The Package Include?
Miss Jamaica, Gabrielle Henry, Falls Off Miss Universe Stage, Ends Up On Stretcher; Video Goes Viral
